Compare Organon Pharma Indonesia Tbk. (SCPI) vs Singaraja Putra Tbk. (SINI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Singaraja Putra Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Singaraja Putra Tbk. trades at Rp13,100 (market cap 16.29T, 13.16M 24h volume). The key difference: Singaraja Putra Tbk. is far larger — about 156× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SINI | |
|---|---|---|
Market Cap | 104.4B | 16.29T |
Volume | — | 13.16M |
Lot | — | 131.6K |
Turnover | — | 174.44B |
Average Price | — | 13,255.29 |
Value | — | 174.44B |
Indicative Equilibrium Price | — | 13,100 |
Indicative Equilibrium Volume | — | 2.97K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Singaraja Putra Tbk.
PT Singaraja Putra Tbk (the Company) was established based on Notarial Deed No. 52 dated November 23, 2005 of Notary Sri Herawati Anwar Effendi, S.H. The Company commenced commercialoperations in 2006.
Read more on SINI →
